Regulatory Challenges in Biomaterials: Focus on Medical Devices - Biomaterials Science: An Integrated Clinical and Engineering Approach - page 268

24. International Conferences on Harmonization website http://www.ich.org
(accessed December 2010).
25. Feldman, M.D., et al. 2008. Who is responsible for evaluating the safety and effec-
tiveness of medical devices? The role of Independent Technology Assessment .
J Gen Inter Med 23(suppl 1): 57-63.
26. Dhruva, S.S. Bero, L.A., Redberg, R.F. 2009. Strength of the evidence examined
by the FDA in premarket approval of cardiovascular devices. JAMA 302(24):
2679-2685.
27. Brown, S.L., Bright, R.A. and Travis, D.R. 2004. Medical device epidemiology
and surveillance: Patient safety is the bottom line. Expert Rev Med Dev 1(1): 1-2.
28. Medical Device Regulations. 2003. Global overview and guiding principles.
World Health Organization Report. Available at http://www.who.int/
whr/2003/en/whr03_en.pdf.
29. Shelby, R.D., Shea, A.M., Schulman, K.A. 2007. Economic implications of poten-
tial changes to regulatory and reimbursement policies for medical devices.
J. Gen. Inter. Med. 23(suppl 1): 50-56.
30. FDA website http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/315.
cfm?GMPPart=878#start (accessed December 2010).
31. FDA website http://www.fda.gov/MedicalDevices/DeviceRegulationand
Guidance/Overview/default.htm.
32. FDA website www.fda.gov/cdrh/devadvice.
33. Saviola, J. 2005. The FDA role in medical devices clinical studies of human sub-
jects. J. Neural Eng 2: S1-S4.
34. Clinical Trials Gov website http://www.clinicaltrials.gov (accessed December
2010).
35. Abded-Aleem, S.A. 2009. Design, Execution and Management of Clinical Trials .
Haboken, NJ: Wiley.
36. Doval, H., et al. 2010. Handbook of Clinical Trials and Statistics ( Manual de Ensayos
Clinicos y Estadistica ). Buenos Aires. Ed GEDIC.
37. Sedrakyan, A., et al. 2010. A framework for evidence evaluation and method-
ological issues in medical device development. Med Care 48 S121-S128.
38. Lawrence M.F., Furberg, C.D., and De Mets, D.L. (2010). Fundamentals of Clinical
Trials. 4th ed. pp. 1-5. New York: Springer.
39. Thuesen, L., and Holm, N.R. 2010. Late coronary stent thrombosis. Minerva Med
101(1): 25-33.
40. Iancu, A., Grosz, C. and Lazar, A. 2010. Acute carotid stent thrombosis: Review
of the literature and long-term follow-up. Cardiovas Revas Med 11(2): 110-113.
41. FDA website http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/
default.htm (accessed December 2010).
42. Reed, S.D., Shea, A.M. and Schulman, K.A. 2007. Economic implications of
potential changes to regulatory and reimbursement policies for medical devices.
J Ger Int Med 23(suppl 1): 50-56.
43. Findlay, R.J. 1999. Originator drug development. Food and Drug Law Journal 54: 227.
44. Turk, B. 2006. Targeting proteases successes, failures and future prospects.
Nature Review Drug Discovery 5: 785-799.
45. Staples, M., et al. 2006. Application of micro- and nano-electromechanical
devices to drug delivery. Pharmaceutical Research 23(5): 847-863.
46. Annas, G.J., and Elias S. 1999. Thalidomide and the Titanic: Reconstructing the
technology tragedies of the twentieth century. Am. J. Public Health 89: 98-101.